Gerhard Gründer
Prof. Dr., Head of Department of Molecular Neuroimaging at the Central Institute of Mental Health (Mannheim)
Key Impact
He is a leading clinical researcher on psilocybin for treatment-resistant depression and a prominent contributor to the implementation of psychedelic therapies in European psychiatric care.
Background & Research
Gerhard Gründer is a psychiatrist and professor at the Central Institute of Mental Health in Mannheim, where he heads the Department of Molecular Neuroimaging. His research focuses on the neurobiology and clinical effects of psychotropic substances, especially psilocybin and other psychedelic compounds, and he has led or coauthored major publications on psychedelic therapy, including the EPIsoDE program.
Collaboration Network
5 collaborators· click a node to visit their profile
Full network →